Maxime Lehmann

Maxime Lehmann

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 1998 in Science
Verified
Journal Article
Closed access
PDF file
HSHong-Jun Song
Hong-Jun Song
GMGuo-li Ming
Guo-li Ming
ZHZhigang He
Zhigang He
MLMaxime Lehmann
Maxime Lehmann
LMLisa McKerracher
Lisa McKerracher
MPMu-Ming Poo
Mu-Ming Poo
Nerve growth is regulated by attractive and repulsive factors in the nervous system. Microscopic gradients of Collapsin-1/Semaphorin III/D (Sema III) and myelin-associated glycoprotein trigger repulsive turning responses by growth cones of cultured Xenopus spinal neurons; the repulsion can be converted to attraction by pharmacological activation of the guanosine 3′,5′-monophosphate (cGMP) and adenosine 3′,5′-monophosphate signaling pathways, respectively. Sema III also causes the collapse of cultured rat sensory growth cones, which can be inhibited by activation of the cGMP pathway. Thus cyclic nucleotides can regulate growth cone behaviors and may be targets for designing treatments to alleviate the inhibition of nerve regeneration by repulsive factors.

15 March 2005 in Cancer Research
Verified
Journal Article
Open access
PDF file
EPEddy Pasquier
Eddy Pasquier
SHStépHane Honore
StépHane Honore
BPBertrand Pourroy
Bertrand Pourroy
MJMary Ann Jordan
Mary Ann Jordan
MLMaxime Lehmann
Maxime Lehmann
DBDiane Braguer
Diane Braguer
Microtubule-targeted drugs such as paclitaxel exhibit potent antiangiogenic activity at very low concentrations, but the mechanism underlying such an effect remains unknown. To understand the involvement of microtubules in angiogenesis, we analyzed the dynamic instability behavior of microtubules in living endothelial cells [human microvascular endothelial cells (HMEC-1) and human umbilical vascular endothelial cells (HUVEC)] following 4 hours of paclitaxel treatment. Unexpectedly, antiangiogenic concentrations of paclitaxel (0.1-5 nmol/L) strongly increased microtubule overall dynamicity in both HMEC-1 (86-193%) and HUVEC (54-83%). This increase was associated with increased microtubule growth and shortening rates and extents and decreased mean duration of pauses. The enhancement of microtubule dynamics by paclitaxel seemed to be specific to antiangiogenic concentrations and to endothelial cells. Indeed, cytotoxic concentration (100 nmol/L) of paclitaxel suppressed microtubule dynamics by 40% and 54% in HMEC-1 and HUVECs, respectively, as observed for all tested concentrations in A549 tumor cells. After 4 hours of drug incubation, antiangiogenic concentrations of paclitaxel that inhibited endothelial cell proliferation without apoptosis (1-5 nmol/L) induced a slight decrease in anaphase/metaphase ratio, which was more pronounced and associated with increased mitotic index after 24 hours of incubation. Interestingly, the in vitro antiangiogenic effect also occurred at 0.1 nmol/L paclitaxel, a concentration that did not alter mitotic progression and endothelial cell proliferation but was sufficient to increase interphase microtubule dynamics. Altogether, our results show that paclitaxel mediates antiangiogenesis by an increase in microtubule dynamics in living endothelial cells and suggest that the impairment of interphase microtubule functions is responsible for the inhibition of angiogenesis.

24 November 2015 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ABAnne-Florence Blandin
Anne-Florence Blandin
GRGuillaume Renner
Guillaume Renner
MLMaxime Lehmann
Maxime Lehmann
ILIsabelle Lelong-Rebel
Isabelle Lelong-Rebel
SMSophie Martin
Sophie Martin
MDMonique Dontenwill
Monique Dontenwill
Integrins belong to a large family of αβ heterodimeric transmembrane proteins first recognized as adhesion molecules that bind to dedicated elements of the extracellular matrix and also to other surrounding cells. As important sensors of the cell microenvironment, they regulate numerous signaling pathways in response to structural variations of the extracellular matrix. Biochemical and biomechanical cues provided by this matrix and transmitted to cells via integrins are critically modified in tumoral settings. Integrins repertoire are subjected to expression level modifications, in tumor cells and in surrounding cancer-associated cells, implicated in tumor initiation and progression as well. As critical players in numerous cancer hallmarks, defined by Hanahan and Weinberg in 2011, integrins represent pertinent therapeutic targets. We will briefly summarize here our current knowledge about integrin implications in those different hallmarks focusing primarily on β1 integrins.

1 January 2008 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
ASAmine Sadok
Amine Sadok
VBVéronique Bourgarel-Rey
Véronique Bourgarel-Rey
FGFlorence Gattacceca
Florence Gattacceca
CPClaude Penel
Claude Penel
MLMaxime Lehmann
Maxime Lehmann
INInstitut de Neurophysiopathologie
Institut de Neurophysiopathologie

12 February 1999 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
ARA. Renaudin
A. Renaudin
MLMaxime Lehmann
Maxime Lehmann
JGJ.-A. Girault
J.-A. Girault
LML. McKerracher
L. McKerracher

1 December 2005 in Laboratory Investigation
Verified
Journal Article
Closed access
KOKallech-Ziri Olfa
Kallech-Ziri Olfa
LJLuis José
Luis José
DSDaoud Salma
Daoud Salma
BABazaa Amine
Bazaa Amine
NSNajet Srairi-Abid
Najet Srairi-Abid
MNMarrakchi Naziha
Marrakchi Naziha